ROLE OF NORFENFLURAMINE IN FENFLURAMINE-INDUCED MYDRIASIS

被引：20
|
作者：
KRAMER, R [1 ]
RUBICEK, M [1 ]
TURNER, P [1 ]
机构：
[1] ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND
来源：
JOURNAL OF PHARMACY AND PHARMACOLOGY | 1973年 / 25卷 / 07期
关键词：
D O I：
10.1111/j.2042-7158.1973.tb09161.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：575 / 576
页数：2
相关论文
共 50 条
  • [1] Fenfluramine-induced immunosuppression: an in vivo analysis
    Connor, TJ
    Kelly, JP
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 455 (2-3) : 175 - 185
  • [2] FENFLURAMINE-INDUCED HYPERTHERMIA AND STIMULATION IN RABBIT
    QUOCK, RM
    BEAL, GA
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1976, 13 (03): : 401 - 409
  • [3] Fenfluramine-induced pulmonary vasoconstriction:: role of serotonin receptors and potassium channels
    Belohlávková, S
    Simák, J
    Kokesová, A
    Hnilicková, O
    Hampl, V
    JOURNAL OF APPLIED PHYSIOLOGY, 2001, 91 (02) : 755 - 761
  • [4] EFFECT OF ZOTEPINE ON FENFLURAMINE-INDUCED HYPERTHERMIA IN RATS
    SATOH, H
    FUJIWARA, T
    MORI, J
    SHIMOMURA, K
    ONO, T
    KIKUCHI, H
    JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 34 (02): : 261 - 263
  • [5] TRANSITORY NATURE OF TOLERANCE TO FENFLURAMINE-INDUCED ANOREXIA
    ELLIS, S
    SCHUSTER, CR
    SEIDEN, L
    FEDERATION PROCEEDINGS, 1984, 43 (04) : 1093 - 1093
  • [6] POTENTIATION OF FENFLURAMINE-INDUCED ACTH RELEASE IN MAN BY NALOXONE
    JACKSON, RV
    GRICE, JE
    JACKSON, AJ
    VELLA, RD
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1989, 16 (04) : 263 - 267
  • [7] Fenfluramine-induced pulmonary hypertension associated with poor survival
    Reactions Weekly, 2004, 992 (1) : 3 - 3
  • [8] ACTION OF METHYSERGIDE ON FENFLURAMINE-INDUCED CONTRACTIONS OF SAPHENOUS VEIN
    KIRBY, M
    TURNER, P
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1971, 23 (10) : 801 - &
  • [9] The fenfluramine metabolite (+)-norfenfluramine is vasoactive
    Ni, W
    Li, MW
    Thakali, K
    Fink, GD
    Watts, SW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (02): : 845 - 852
  • [10] The fenfluramine metabolite (+)-norfenfluramine is vasoactive
    Ni, W.
    Li, M.
    Thakali, K.
    Fink, G. D.
    Watts, S. W.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 139 - 139
12345